A detailed history of Bank Of Nova Scotia Trust CO transactions in Abb Vie Inc. stock. As of the latest transaction made, Bank Of Nova Scotia Trust CO holds 1,104 shares of ABBV stock, worth $180,879. This represents 0.02% of its overall portfolio holdings.

Number of Shares
1,104
Holding current value
$180,879
% of portfolio
0.02%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$159.82 - $182.1 $176,441 - $201,038
1,104 New
1,104 $201,000
Q2 2022

Aug 05, 2022

SELL
$137.62 - $174.96 $196,796 - $250,192
-1,430 Closed
0 $0
Q1 2022

May 09, 2022

BUY
$131.98 - $163.75 $188,731 - $234,162
1,430 New
1,430 $232,000
Q3 2021

Nov 12, 2021

SELL
$106.4 - $120.78 $362,717 - $411,739
-3,409 Closed
0 $0
Q2 2021

Aug 12, 2021

BUY
$105.21 - $117.21 $315 - $351
3 Added 0.09%
3,409 $384,000
Q1 2021

May 06, 2021

BUY
$102.3 - $112.62 $2,864 - $3,153
28 Added 0.83%
3,406 $369,000
Q4 2020

Feb 11, 2021

SELL
$80.49 - $108.67 $1,931 - $2,608
-24 Reduced 0.71%
3,378 $362,000
Q3 2020

Nov 12, 2020

BUY
$85.91 - $100.83 $171 - $201
2 Added 0.06%
3,402 $298,000
Q2 2020

Aug 11, 2020

SELL
$73.37 - $98.18 $11,005 - $14,727
-150 Reduced 4.23%
3,400 $334,000
Q4 2019

Feb 13, 2020

SELL
$72.13 - $90.25 $216 - $270
-3 Reduced 0.08%
3,550 $314,000
Q3 2019

Nov 14, 2019

SELL
$62.98 - $75.72 $314 - $378
-5 Reduced 0.14%
3,553 $269,000
Q2 2019

Aug 13, 2019

SELL
$65.7 - $83.98 $22,469 - $28,721
-342 Reduced 8.77%
3,558 $259,000
Q4 2018

Feb 11, 2019

SELL
$77.85 - $96.01 $62,980 - $77,672
-809 Reduced 17.18%
3,900 $360,000
Q4 2017

Feb 13, 2018

SELL
$89.56 - $98.21 $326,446 - $357,975
-3,645 Reduced 43.63%
4,709 $455,000
Q3 2017

Nov 14, 2017

BUY
$69.85 - $89.22 $2,095 - $2,676
30 Added 0.36%
8,354 $743,000
Q2 2017

Aug 14, 2017

BUY
N/A
8,324
8,324 $604,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $290B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Bank Of Nova Scotia Trust CO Portfolio

Follow Bank Of Nova Scotia Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Nova Scotia Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Nova Scotia Trust CO with notifications on news.